Grifols, S.A. (GRFS)

NASDAQ: GRFS · Real-Time Price · USD
8.60
+0.14 (1.65%)
At close: Nov 20, 2024, 4:00 PM
8.45
-0.15 (-1.74%)
Pre-market: Nov 21, 2024, 4:42 AM EST
1.65%
Market Cap 6.84B
Revenue (ttm) 7.81B
Net Income (ttm) 180.11M
Shares Out 679.63M
EPS (ttm) 0.27
PE Ratio 37.97
Forward PE 10.79
Dividend n/a
Ex-Dividend Date n/a
Volume 625,230
Open 8.45
Previous Close 8.46
Day's Range 8.37 - 8.61
52-Week Range 5.30 - 12.15
Beta 0.69
Analysts Sell
Price Target 10.50 (+22.09%)
Earnings Date n/a

About GRFS

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factorVIII/von Willerbrand factor and factor IX, clotting factors for the treatment of hemophilia A and... [Read more]

Sector Healthcare
IPO Date May 17, 2006
Employees 23,737
Stock Exchange NASDAQ
Ticker Symbol GRFS
Full Company Profile

Financial Performance

In 2023, Grifols's revenue was 6.59 billion, an increase of 8.71% compared to the previous year's 6.06 billion. Earnings were 59.32 million, a decrease of -71.52%.

Financial numbers in EUR Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for GRFS stock is "Sell." The 12-month stock price forecast is $10.5, which is an increase of 22.09% from the latest price.

Price Target
$10.5
(22.09% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Grifols: Brookfields potential $6.8 bln offer undervalues the firm

Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential.

1 day ago - Reuters

Spanish court opens investigation into Gotham City's attack on Grifols

An investigating magistrate at the Spanish High Court said on Tuesday it had opened an investigation into U.S.-based short seller Gotham City's actions that brought down the share price of Spanish pha...

2 days ago - Reuters

Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors

NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company”) (BME: G...

2 days ago - Business Wire

Brookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial says

Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing source...

3 days ago - Reuters

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors

NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company”) (BME: G...

12 days ago - Business Wire

Grifols on track to meet 2024 targets despite third-quarter profit drop

Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago.

13 days ago - Reuters

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down

Grifols, S.A. is undervalued and worth more than its current market valuation, making it a strong buy even without a potential Brookfield buyout. The company leads the global plasma market, with signi...

6 weeks ago - Seeking Alpha

Grifols plans to invest $402 million in new industrial centre, El Economista says

Spanish drugmaker Grifols plans to invest 360 million euros ($401.98 million) to build a new industrial plant in Barcelona for its engineering department, newspaper El Economista said on Monday, citin...

7 weeks ago - Reuters

Significant Shareholders Exercise Right to Grifols Board Seat

BARCELONA, Spain--(BUSINESS WIRE)--Significant Grifols shareholders fill a vacant board seat, appointing pharma leader Paul Herendeen to drive value and improve governance.

2 months ago - Business Wire

Grifols Egypt Collaborates with Orange Business to Deliver New Data Center and Communications Infrastructure, Supporting Advanced Medical Processes

CAIRO--(BUSINESS WIRE)--Orange Business is pleased to announce the successful completion of the first phase of a new data center and communications infrastructure for Grifols Egypt for its Plasma Deri...

2 months ago - Business Wire

The Schall Law Firm Is Looking Into Grifols SA For Possible Securities Related Improprieties And Stockholders Are Invited To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A....

2 months ago - Accesswire

Grifols S.A. May Have Committed Fraud And Investors Are Urged To Contact The Schall Law Firm About An Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A....

2 months ago - Accesswire

The Schall Law Firm Is Looking Into Grifols SA For Possibly Violating Securities Laws And Stakeholders Are Invited To Partake In The Investigation

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for vio...

2 months ago - Accesswire

Grifols SA May Have Committed Securities Fraud And Investors With Losses Should Join The Schall Law Firm's Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A....

2 months ago - Accesswire

An Investigation Has Been Launched By The Schall Law Firm Into Grifols S.A.'s Possible Securities Law Violations And Shareholders Can Join

LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A....

2 months ago - Accesswire

Grifols SA Is Being Looked Into For Securities Fraud And Investors Should Reach Out To The Schall Law Firm About The Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A....

2 months ago - Accesswire

The Schall Law Firm Wants The Public To Participate In An Investigation Into Grifols S.A.'s Possible Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

2 months ago - Accesswire

Grifols SA May Have Committed Securities Fraud And Stakeholders Are Invited To Join The Schall Law Firm's Inquiry

LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

2 months ago - Accesswire

The Schall Law Firm Is Looking Into Whether Grifols S.A. Violated Securities Regulations And Investors Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

2 months ago - Accesswire

An Investigation Has Been Launched Into Grifols SA For Securities Fraud And The Schall Law Firm Invites Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire

Grifols SA Is Being Inquired Into For Securities Violations And Investors Are Encouraged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire

The Schall Law Firm Urges Shareholders To Join An Investigation Into Grifols SA's Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire

An Inquiry Has Been Launched Into Grifols SA For Securities Law Infractions And The Schall Law Firm Is Seeking Investor Participation

LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire

Grifols SA Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To Take Part

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire

The Schall Law Firm Has Launched An Inquiry Into Grifols SA For Potential Securities Violations And Stockholders Are Invited To Assist

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. (...

3 months ago - Accesswire